Intensity Therapeutics, Inc.
INTS
$0.282
-$0.009-3.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 48.96% | 27.29% | -0.28% | -50.84% | -34.32% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.05% | -62.02% | 104.20% | 45.89% | -77.15% |
| Change in Net Operating Assets | -456.25% | 199.24% | -120.20% | 69.01% | -77.24% |
| Cash from Operations | 41.72% | 54.44% | -182.03% | 22.41% | -1,663.18% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | 135.05% | -- |
| Cash from Investing | -- | -- | -100.00% | 135.05% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 155,766.67% | 4,212.50% | -- | -97.80% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 95.80% | -- |
| Cash from Financing | 124,666.67% | 4,000.00% | 19,146.15% | -97.99% | 101.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 130.52% | -51.28% | -110.31% | -107.00% | -778.54% |